Skip to main content
. 2021 Sep 28;13(19):4868. doi: 10.3390/cancers13194868

Table 1.

Details concerning data collection.

Data Collection Before Inclusion Baseline Assessment (T0) Assessment Post-Intervention (T1)
Signature of Informed Consent graphic file with name cancers-13-04868-i001.jpg
Clinical Examination
Including medical history ECOG and vital signs		 graphic file with name cancers-13-04868-i001.jpg
Cognitive Assessment AND Quality of Life Questionnaires
FACT-COG graphic file with name cancers-13-04868-i001.jpg graphic file with name cancers-13-04868-i001.jpg
MoCA graphic file with name cancers-13-04868-i001.jpg
CNS Vital signs battery graphic file with name cancers-13-04868-i001.jpg graphic file with name cancers-13-04868-i001.jpg
HADS, FACIT-F, ISI graphic file with name cancers-13-04868-i001.jpg graphic file with name cancers-13-04868-i001.jpg
Patient’s Satisfaction graphic file with name cancers-13-04868-i001.jpg

ECOG: Scale of Performance Status; FACT-COG: Functional Assessment of Cancer Therapy—Cognitive Function; MoCA: Montreal Cognitive Asessment; HADS: Hospital Anxiety and Depresion Scale; FACIT-F: The Functional Assessment of Chronic Illness Therapy—Fatigue; ISI: Insomnia Severity Index.